Literature DB >> 27567275

Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?

Uri Galili1.   

Abstract

Humans produce multiple natural antibodies against carbohydrate antigens on gastrointestinal bacteria. Two such antibodies appeared in primates in recent geological times. Anti-Gal, abundant in humans, apes and Old-World monkeys, appeared 20-30 million years ago (mya) following inactivation of the α1,3GT gene (GGTA1). This gene encodes in other mammals the enzyme α1,3galactosyltransferase (α1,3GT) that synthesizes α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R) which bind anti-Gal. Anti-Neu5Gc, found only in humans, appeared in hominins <6 mya, following elimination of N-glycolylneuraminic-acid (Neu5Gc) because of inactivation of CMAH, the gene encoding hydroxylase that converts N-acetylneuraminic-acid (Neu5Ac) into Neu5Gc. These antibodies, were initially produced in few individuals that acquired random mutations inactivating the corresponding genes and eliminating α-gal epitopes or Neu5Gc, which became nonself antigens. It is suggested that these evolutionary selection events were induced by epidemics of enveloped viruses, lethal to ancestral Old World primates or hominins. Such viruses presented α-gal epitopes or Neu5Gc, synthesized in primates that conserved active GGTA1 or CMAH, respectively, and were lethal to their hosts. The natural anti-Gal or anti-Neu5Gc antibodies, produced in offspring lacking the corresponding carbohydrate antigens, neutralized and destroyed viruses presenting α-gal epitopes or Neu5Gc. These antibodies further induced rapid, effective immune responses against virus antigens, thus preventing infections from reaching lethal stages. These epidemics ultimately resulted in extinction of primate populations synthesizing these carbohydrate antigens and their replacement with offspring populations lacking the antigens and producing protective antibodies against them. Similar events could mediate the elimination of various carbohydrate antigens, thus preventing the complete extinction of other vertebrate species.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Neu5Gc; anti-Gal; anti-Neu5Gc; natural anti-carbohydrate antibodies; primate evolution; virus carbohydrates.; α-gal epitope

Mesh:

Substances:

Year:  2016        PMID: 27567275     DOI: 10.1093/glycob/cww088

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  14 in total

1.  The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies.

Authors:  Peter Jandus; Kayluz Frias Boligan; David F Smith; Elisabeth de Graauw; Bodo Grimbacher; Camilla Jandus; Mai M Abdelhafez; Alain Despont; Nicolai Bovin; Dagmar Simon; Robert Rieben; Hans-Uwe Simon; Richard D Cummings; Stephan von Gunten
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

Review 2.  Immune disguise: the mechanisms of Neu5Gc inducing autoimmune and transplant rejection.

Authors:  Fadian Ding; Yunfeng Lin; Guozhong Liu; Yuxin Liu; Feng Gao; Qicai Liu; Zhibo Zhang; Shangeng Weng
Journal:  Genes Immun       Date:  2022-09-23       Impact factor: 4.248

3.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

4.  The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity.

Authors:  Jens Magnus Bernth Jensen; Sune Skeldal; Mikkel Steen Petersen; Bjarne Kuno Møller; Steen Hoffmann; Jens Christian Jensenius; Uffe B Skov Sørensen; Steffen Thiel
Journal:  Immunology       Date:  2021-01-04       Impact factor: 7.397

Review 5.  Engineering Efforts to Refine Compatibility and Duration of Aortic Valve Replacements: An Overview of Previous Expectations and New Promises.

Authors:  Stefano Rizzi; Sara Ragazzini; Maurizio Pesce
Journal:  Front Cardiovasc Med       Date:  2022-04-18

6.  Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection.

Authors:  Raghubendra Singh Dagur; Amanda Branch-Woods; Saumi Mathews; Poonam S Joshi; Rolen M Quadros; Donald W Harms; Yan Cheng; Shana M Miles; Samuel J Pirruccello; Channabasavaiah B Gurumurthy; Santhi Gorantla; Larisa Y Poluektova
Journal:  BMC Immunol       Date:  2019-01-07       Impact factor: 3.615

Review 7.  Exploitation of glycosylation in enveloped virus pathobiology.

Authors:  Yasunori Watanabe; Thomas A Bowden; Ian A Wilson; Max Crispin
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-05-20       Impact factor: 3.770

Review 8.  Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.

Authors:  Sharon Yehuda; Vered Padler-Karavani
Journal:  Front Immunol       Date:  2020-01-23       Impact factor: 7.561

Review 9.  The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation.

Authors:  Alfred Joseph Tector; Mathilde Mosser; Matthew Tector; Jean-Marie Bach
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

10.  Ticks, Hair Loss, and Non-Clinging Babies: A Novel Tick-Based Hypothesis for the Evolutionary Divergence of Humans and Chimpanzees.

Authors:  Jeffrey G Brown
Journal:  Life (Basel)       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.